Al Nimer et al. reported a significant increase in LCN2 expression in patients with progressive MS, and LCN2 levels were several times higher in the brain tissue than that in cerebrospinal fluid, suggesting that LCN2 levels are closely associated with WM demyelination [9]. This evidence concerns the gene LCN2 and myeloid sarcoma.